CN109724933A - A kind of reproducible aspartate amino transferase detection kit - Google Patents

A kind of reproducible aspartate amino transferase detection kit Download PDF

Info

Publication number
CN109724933A
CN109724933A CN201811653698.1A CN201811653698A CN109724933A CN 109724933 A CN109724933 A CN 109724933A CN 201811653698 A CN201811653698 A CN 201811653698A CN 109724933 A CN109724933 A CN 109724933A
Authority
CN
China
Prior art keywords
reagent
reproducible
amino transferase
aspartate amino
detection kit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201811653698.1A
Other languages
Chinese (zh)
Inventor
甘宜梧
罗维晓
王美丽
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biobase Biodustry Shandong Co Ltd
Original Assignee
Biobase Biodustry Shandong Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biobase Biodustry Shandong Co Ltd filed Critical Biobase Biodustry Shandong Co Ltd
Priority to CN201811653698.1A priority Critical patent/CN109724933A/en
Publication of CN109724933A publication Critical patent/CN109724933A/en
Pending legal-status Critical Current

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The present invention relates to biochemistry detection technical field, in particular to a kind of reproducible aspartate amino transferase detection kit and its preparation, application method.It includes reagent R1 and reagent R2, and wherein reagent R1 includes buffer, pH value adjustment agent, ASPARTIC ACID, potassium ferrocyanide, AP5A, EGTA, lithium chloride, surfactant, left-handed glucosides, lactic dehydrogenase, malic dehydrogenase, preservative component, reagent R2 include buffer, pH value adjustment agent, BSA, preservative, a-ketoglutaric acid, NADH component.The present invention is optimized from removal reflection interference, the activity for improving the enzyme reacted, the homogeneity for improving reaction system and preferably excellent commplementary wave length etc., the present invention significantly improves the repeatability of reagent, the especially repeatability of low value sample, to be conducive to improve the accuracy of clinical diagnosis result, there is very big value for clinical application.

Description

A kind of reproducible aspartate amino transferase detection kit
Technical field
The invention belongs to biochemistry detection technical fields, and in particular to a kind of reproducible aspartate amino transferase Detection kit and its preparation, application method.
Background technique
Aspartate amino transferase (aspartate aminotransferase, AST), is present in various groups of human body It is most abundant with levels and myocardial contents in knitting, followed by liver.Under normal circumstances, content of the AST in serum is very low, works as linked groups When organ damages, concentration of the AST in serum can occur to change accordingly.
Liver blood detection is the most common blood testing, can be used for assessing liver function or hepatic injury.Chronic hepatitis is suffered from The most common laboratory of person checks that abnormal is that serum transaminase increases, common serum aspartate transaminase (AST).AST master It is distributed in liver cell, sub-fraction is present in muscle cell.Transaminase if liver damage or damage, in liver cell Just enter blood, AST level increases in blood, prompts liver diseases signal.Wherein AST is most sensitive, it is in hepatic tissue Activity is 100 times in serum, as long as there is 1% necrosis of liver cells, the AST in serum can be made to increase by 1 times.Therefore, most of In the case of AST elevated-levels it is consistent with the liver cell extent of damage, be most common Liver function grade index.
The measurement of serum aspartate amino transferase facilitates the judgement heart and liver cell, and whether there is or not necrosis and degree of injury. AST increases: being common in acute and chronic serious hepatitis, cirrhosis, myocarditis, myocardial infarction, ephritis, cholangitis, dermatomyositis, pancreas The illnesss such as inflammation.AST is reduced: over fatigue, the diseases such as malnutritive and serious later period of hepatocarcinoma.
The detection method of AST uses ultraviolet spectrophotometry mainly in combination with automatic clinical chemistry analyzer device in clinical application To the content of the AST in human serum or blood plasma by way of continuously detecting, testing principle is main are as follows:
ASPARTIC ACID and α-ketoglutaric acid generate oxaloacetic acid and Pidolidone, oxalyl second under AST enzymatic reaction Acid and reduced coenzyme Ⅰ (NADH) generate L MALIC ACID and cozymase, reduction under the catalytic action of malic dehydrogenase (MDH) The rate of type cozymase (NADH) consumption and the activity of sample Mid-Heaven Gate aspartic acid aminopherase (AST) are directly proportional, pass through measurement The activity of sample Mid-Heaven Gate aspartic acid aminopherase (AST) can be obtained in the change rate of absorbance at 340nm.
The detection method has at low cost, the advantages such as mass detection speed is fast, accuracy is good, at present in clinic It is widely applied, but this method is often repeated very undesirable for the low value sample occurred in clinic, in some precision In slightly worse instrument and equipment, the problem of poor repeatability of performance, can more be protruded, and the sample of normal person is generally concentrated at 12- In the range of 40U/L, and tool is diagnosed lower than patient of the patient's sample of normal reference range for liver tumour advanced stage in clinic There is important reference significance, and the sample in normal reference range is relatively low, therefore improves this method product Repeatability also has very important practical value.
For this problem, the reason that examen causes repeatability undesirable is invented a kind of with good reproducibility Aspartate amino transferase (AST) detection kit and application method, utilize clinical popularization and use.
Summary of the invention
To solve the above problems, the purpose of the present invention is to provide a kind of reproducible aspartate amino transferases Detection kit, using the method continuously detected based on uv-spectrophotometric, by the interfering substance of removal interference repeatability, It improves the homogeneity of reaction system and improves the methods of the sensitivity of enzyme reaction, invent a kind of reproducible asparatate Transamination enzyme detection kit and its preparation, application method.
To achieve the above object, the present invention is achieved by the following technical solutions: a kind of reproducible asparagine Sour transamination enzyme detection kit comprising reagent R1 and reagent R2,
The reagent R1 includes the component of following content:
The reagent R2 includes the component of following content:
A kind of reproducible aspartate amino transferase detection kit, it is characterised in that: buffered in reagent R1 Liquid is 25 DEG C, pH are as follows: 7.4 Tris buffer;Buffer is 25 DEG C in reagent R2, the CAPS buffer that pH is 9.8.
A kind of reproducible aspartate amino transferase detection kit, it is characterised in that: the pH value adjustment Agent is lithium hydroxide or tartaric acid.
A kind of reproducible aspartate amino transferase detection kit, it is characterised in that: the preservative is Polylysine.
A kind of reproducible aspartate amino transferase detection kit, it is characterised in that: the surface-active Agent 1 is that Qula leads to -108 (SIGMA)), surfactant 2 is oleamide propyl betaine (Japanese Kao).
A kind of application method of reproducible aspartate amino transferase detection kit, it is characterised in that: make Be measured with automatic clinical chemistry analyzer using end-point method, detection dominant wavelength be 340nm, a length of 546nm of complementary wave, R1 reagent and The ratio of R2 reagent is 4:1.
The beneficial effects of the present invention are:
1) this law is bright according to preferred Tris buffer in reagent R1 the characteristics of enzyme in reagent and substrate, in reagent R2 preferably CAPS buffer, and the preferred lithium hydroxide of purpose PH required for adjusting and tartaric acid are as regulator, buffer and PH The activity of value regulator preferably facilitated etc. than improving catalysis reaction, utilizes the raising of repeatability;
2) present invention increase AP5A assists in removing interference of the kinases to reaction in dry blood, and potassium ferrocyanide is added with Help remove interference of the fluctuation of bilirubin to continuous detection method, the repeatability of detection reagent is improved in terms of removing chaff interferent;
3) two kinds of surfactant Qulas logical -108 and oleamide propyl betaine be advantageously selected for reaction solution is fast The homogenization of speed, improves the uniformity of detection reaction every time, and reaction solution is promoted more to clarify, and increases the permeability of optical path, from And improve the repeatability of detection detected every time;
4) the preferred EGTA metal-chelator of property in the present invention also according to key tool enzyme in reagent, reduces heavy metal The inhibiting effect of ions enzyme, preferably polylysine effectively inhibit as preservative the growth of bacterial micro-organism in reagent, Increase the protective agents such as left-handed glucosides, bovine serum albumin(BSA) in reagent come property the problem of improving enzyme, guarantees that enough enzymatic activitys participate in Reaction.
5) present invention preferably 546nm can be interfered as commplementary wave length caused by effective compensation apparatus fluctuation, and to detection As a result it will not have an impact.
Specific embodiment
In order to be easy to understand the technical means, the creative features, the aims and the efficiencies achieved by the present invention, tie below Closing specific embodiment, invention is further explained:
Embodiment 1
1) detection reagent of the common aspartate amino transferase of one kind provided by the present embodiment (AST), including Reagent R1 and reagent R2, concrete composition ingredient:
Reagent R1:
Reagent R2:
2) application method of the present embodiment reagent:
Common aspartate amino transferase (AST) detection kit of one kind of the present embodiment description, when in use Using the automatic clinical chemistry analyzer with double reagent function, such as 7180 fully-automatic analyzer of Hitachi, Rate A method is utilized It is measured.R1 and R2 is placed on corresponding reagent position according to the ratio of 4:1, places steaming in the corresponding position of sample disc Distilled water, standard items and sample, operation such as table 1.
1 reagent test method table of table
It calculates: aspartate amino transferase (AST) content (U/L) with good reproducibility=(Δ A measures ÷ Δ A standard) × C standard
Embodiment 2
The reproducible aspartate amino transferase detection kit of one kind described in the present embodiment, packet reagent R1 With reagent R2:
1) component of reagent R1 includes:
The reagent R2 includes the component of following content:
2) application method of the present embodiment reagent:
The present embodiment reagent is when in use using the automatic clinical chemistry analyzer with double reagent function, as Hitachi 7180 is complete Automatic analyzer etc. is measured using Rate A method.R1 and R2 is placed into corresponding reagent position according to the ratio of 4:1 On, distilled water, standard items and sample, operation such as table 2 are placed in the corresponding position of sample disc.
2 reagent test method table of table
It calculates: aspartate amino transferase (AST) content (U/L) with good reproducibility=(Δ A measures ÷ Δ A standard) × C standard
Embodiment 3
The reproducible aspartate amino transferase detection kit of one kind described in the present embodiment, packet reagent R1 With reagent R2:
1) component of reagent R1 includes:
The reagent R2 includes the component of following content:
2) application method of the present embodiment is the same as embodiment 2.
Repeated performance verification:
Repetitive test: choosing high level, intermediate value, low value, each two groups of clinical sample of four different stages of extremely low value respectively, Control test is carried out with embodiment 1-3 respectively, 20 detections are carried out to every part of sample, totally 20 testing results will be calculated averagely Value, standard deviation and the coefficient of variation.It the results are shown in Table 3.
Table 3-1 high level sample repeatability testing result
Table 3-2 intermediate value sample repeatability testing result
Table 3-3 low value sample repeatability testing result
The extremely low value sample repeatability testing result of table 3-4
By the CV% coefficient of variation in table 3 it is found that compared with comparative example 1-3, embodiment 2 and the coefficient of variation implemented in 3 are equal Smaller, especially in terms of low value sample and extremely low value sample, testing result has preferably repeatability, this illustrates the present invention By adjusting reaction system, increases the methods of anti-interference agent, optimizes reaction process, greatly improve the repeatability of reagent, The especially repeatability of low value sample, effect is clearly.

Claims (6)

1. a kind of reproducible aspartate amino transferase detection kit, it is characterised in that: it include reagent R1 and Reagent R2,
The reagent R1 includes the component of following content:
The reagent R2 includes the component of following content:
2. the reproducible aspartate amino transferase detection kit of one kind according to claim 1, feature It is: trishydroxymethylaminomethane (Tris) buffer that buffer is 25 DEG C in reagent R1, pH is 7.4;It is buffered in reagent R2 Liquid is 25 DEG C, 3- (cyclohexylamine) -1- propane sulfonic acid (CAPS) buffer that pH is 9.8.
3. the reproducible aspartate amino transferase detection kit of one kind according to claim 1, feature Be: the pH value adjustment agent is lithium hydroxide or tartaric acid.
4. the reproducible aspartate amino transferase detection kit of one kind according to claim 1, feature Be: the preservative is polylysine.
5. the reproducible aspartate amino transferase detection kit of one kind according to claim 1, feature Be: the surfactant 1 is that Qula leads to -108 (SIGMA)), surfactant 2 is oleamide propyl betaine (Japan Flower king).
6. the reproducible aspartate amino transferase detection reagent of one kind described in -5 any one according to claim 1 The application method of box, it is characterised in that: be measured using automatic clinical chemistry analyzer using end-point method, detection dominant wavelength is The ratio of 340nm, a length of 546nm of complementary wave, R1 reagent and R2 reagent is 4:1.
CN201811653698.1A 2018-12-30 2018-12-30 A kind of reproducible aspartate amino transferase detection kit Pending CN109724933A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811653698.1A CN109724933A (en) 2018-12-30 2018-12-30 A kind of reproducible aspartate amino transferase detection kit

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811653698.1A CN109724933A (en) 2018-12-30 2018-12-30 A kind of reproducible aspartate amino transferase detection kit

Publications (1)

Publication Number Publication Date
CN109724933A true CN109724933A (en) 2019-05-07

Family

ID=66299593

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811653698.1A Pending CN109724933A (en) 2018-12-30 2018-12-30 A kind of reproducible aspartate amino transferase detection kit

Country Status (1)

Country Link
CN (1) CN109724933A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115655848A (en) * 2022-12-26 2023-01-31 河北盛华尔生物医疗科技有限公司 Stable glutamic-oxaloacetic transaminase determination kit
WO2023060818A1 (en) * 2021-10-12 2023-04-20 广州达安基因股份有限公司 In-vitro diagnostic reagent preservative and use thereof

Citations (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0463755A1 (en) * 1990-06-27 1992-01-02 INSTRUMENTATION LABORATORY S.p.A. Stable aqueous NADH reagent and kit
JPH06245798A (en) * 1993-02-24 1994-09-06 Toyobo Co Ltd Got assay and reagent therefor
CN1892221A (en) * 2005-06-29 2007-01-10 希森美康株式会社 Clinical diagnostic reagent comprising glucose 6-phosphate dehydrogenase (G6PDH), method for stabilizing G6PDH, and use of a stabilizer for g6pdh
CN103320498A (en) * 2013-05-24 2013-09-25 宁波美康生物科技股份有限公司 Detection reagent for aspartate aminotransferase
CN104198474A (en) * 2014-08-14 2014-12-10 上海睿康生物科技有限公司 Detection kit for measuring content of lipase in serum by colorimetric method
CN104198408A (en) * 2014-08-14 2014-12-10 上海睿康生物科技有限公司 Detection kit for determining content of creatinine in serum by enzymic method
CN104198407A (en) * 2014-08-14 2014-12-10 上海睿康生物科技有限公司 Detection kit for detecting content of beta-hydroxybutyrate in serum by adopting stable enzymatic method
CN104390925A (en) * 2014-10-20 2015-03-04 苏州康铭诚业医用科技有限公司 Composite stabilizer for aspartate aminotransferase assay kit
CN105203533A (en) * 2015-09-14 2015-12-30 郁东 Detection reagent for N-acetyl-beta-D-glucosaminidase with high analytical sensitivity
CN105985942A (en) * 2016-04-27 2016-10-05 上海多米瑞生物技术有限公司 Protective agent for lysylendopeptidase freeze-drying and storage
CN106093401A (en) * 2016-07-25 2016-11-09 浙江聚康生物工程有限公司 A kind of diagnostic kit detecting thymidine kinase 1
CN106644976A (en) * 2016-10-03 2017-05-10 王贤俊 Aspartate amino transferase detection kit
CN107988315A (en) * 2017-11-24 2018-05-04 宁波美康保生生物医学工程有限公司 CK, CKMB, LDH and AST combined detection reagent
CN108169493A (en) * 2017-12-27 2018-06-15 山东博科生物产业有限公司 A kind of serum amyloid A protein detection kit and its preparation, application method
CN108192949A (en) * 2017-12-29 2018-06-22 章丘永耐医疗器械有限公司 A kind of aspartate amino transferase detection kit
CN108287233A (en) * 2017-12-21 2018-07-17 济南品鑫生物科技有限公司 A kind of enzyme process uric acid detection reagent of strong antijamming capability
CN108845140A (en) * 2018-05-04 2018-11-20 湖北科技学院 Kit for determining alanine aminopherase

Patent Citations (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0463755A1 (en) * 1990-06-27 1992-01-02 INSTRUMENTATION LABORATORY S.p.A. Stable aqueous NADH reagent and kit
JPH06245798A (en) * 1993-02-24 1994-09-06 Toyobo Co Ltd Got assay and reagent therefor
CN1892221A (en) * 2005-06-29 2007-01-10 希森美康株式会社 Clinical diagnostic reagent comprising glucose 6-phosphate dehydrogenase (G6PDH), method for stabilizing G6PDH, and use of a stabilizer for g6pdh
CN103320498A (en) * 2013-05-24 2013-09-25 宁波美康生物科技股份有限公司 Detection reagent for aspartate aminotransferase
CN104198474A (en) * 2014-08-14 2014-12-10 上海睿康生物科技有限公司 Detection kit for measuring content of lipase in serum by colorimetric method
CN104198408A (en) * 2014-08-14 2014-12-10 上海睿康生物科技有限公司 Detection kit for determining content of creatinine in serum by enzymic method
CN104198407A (en) * 2014-08-14 2014-12-10 上海睿康生物科技有限公司 Detection kit for detecting content of beta-hydroxybutyrate in serum by adopting stable enzymatic method
CN104390925A (en) * 2014-10-20 2015-03-04 苏州康铭诚业医用科技有限公司 Composite stabilizer for aspartate aminotransferase assay kit
CN105203533A (en) * 2015-09-14 2015-12-30 郁东 Detection reagent for N-acetyl-beta-D-glucosaminidase with high analytical sensitivity
CN105985942A (en) * 2016-04-27 2016-10-05 上海多米瑞生物技术有限公司 Protective agent for lysylendopeptidase freeze-drying and storage
CN106093401A (en) * 2016-07-25 2016-11-09 浙江聚康生物工程有限公司 A kind of diagnostic kit detecting thymidine kinase 1
CN106644976A (en) * 2016-10-03 2017-05-10 王贤俊 Aspartate amino transferase detection kit
CN107988315A (en) * 2017-11-24 2018-05-04 宁波美康保生生物医学工程有限公司 CK, CKMB, LDH and AST combined detection reagent
CN108287233A (en) * 2017-12-21 2018-07-17 济南品鑫生物科技有限公司 A kind of enzyme process uric acid detection reagent of strong antijamming capability
CN108169493A (en) * 2017-12-27 2018-06-15 山东博科生物产业有限公司 A kind of serum amyloid A protein detection kit and its preparation, application method
CN108192949A (en) * 2017-12-29 2018-06-22 章丘永耐医疗器械有限公司 A kind of aspartate amino transferase detection kit
CN108845140A (en) * 2018-05-04 2018-11-20 湖北科技学院 Kit for determining alanine aminopherase

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023060818A1 (en) * 2021-10-12 2023-04-20 广州达安基因股份有限公司 In-vitro diagnostic reagent preservative and use thereof
CN115655848A (en) * 2022-12-26 2023-01-31 河北盛华尔生物医疗科技有限公司 Stable glutamic-oxaloacetic transaminase determination kit
CN115655848B (en) * 2022-12-26 2023-03-17 河北盛华尔生物医疗科技有限公司 Stable glutamic-oxaloacetic transaminase determination kit

Similar Documents

Publication Publication Date Title
Utter et al. 4 Formation of Oxalacetate by CO2 Fixation on Phosphoenolpyruvate
CN105203472A (en) Stable NEFA (non-esterified fatty acid) measuring kit
CN109724933A (en) A kind of reproducible aspartate amino transferase detection kit
Viola et al. Use of pH studies to elucidate the chemical mechanism of yeast hexokinase
Karsten et al. Kinetic studies of L-aspartase from Escherichia coli: substrate activation
Fleshood et al. The Metabolism of O-Phosphorylethanolamine in Animal Tissues: I. O-PHOSPHORYLETHANOLAMINE PHOSPHO-LYASE: PARTIAL PURIFICATION AND CHARACTERIZATION
Canellas et al. Substrate and metal ion interactions in the NAD+ malic enzyme from cauliflower
AGNARP et al. Interaction of pyridine-nucleotide linked enzymes
Smith et al. The effects of infection by Phytophthora infestans on the control of phenylpropanoid metabolism in wounded potato tissue
Schadewaldt et al. Coupled Enzymatic Assay for Estimation of Branched-Chainl-Amino Acid Aminotransferase Activity with 2-Oxo Acid Substrates
Viswanathan et al. . alpha.-Ketoglutaric acid: solution structure and the active form for reductive amination by bovine liver glutamate dehydrogenase
Peczon et al. Catalytic sites in rabbit muscle glyceraldehyde-3-phosphate dehydrogenase. Their number and their kinetic and spectral properties
CA1144459A (en) Method for determination of transaminases and relative diagnostic kit
US4229527A (en) Process and reagent for the kinetic determination of enzyme substrates
Daley et al. Characterization of phosphoenolpyruvate carboxykinase from pineapple leaves Ananas comosus (L.) Merr.
CN106811505B (en) Single-reagent liquid ammonia blood (AMM) detection reagent with strong stability
CN1311335A (en) Reagent for stabilizing reducing coenzyme I and reducing coenzyme II
Andreo et al. Chemical modification of the phosphoenolpyruvate carboxylase from maize leaves and its conformation in isotropic solution. Studies via triplet lifetime and rotational diffusion using eosin isothiocyanate as label
Rej Measurement of aspartate aminotransferase activity: effects of oxamate.
Stoll et al. A simple HPLC technique for accurate monitoring of mammalian cell metabolism
CN104195220B (en) A kind of kit for human serum determining alanine aminopherase
EP0076478B1 (en) Linear kinetic determination of bicarbonate in body fluids
LA Characterization of Enzyme-Pyridoxal Phosphate Complex
CN111500673A (en) Angiotensin converting enzyme assay kit and preparation method and application thereof
CN108192949A (en) A kind of aspartate amino transferase detection kit

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20190507

RJ01 Rejection of invention patent application after publication